McKesson market cap MCK

Share price times shares outstanding: what the whole company sells for, since 2009.

McKesson is worth $116.7B at the close on Oct 23, 2026, at $1,000.77 a share.

That is up 17% over the last year and up 263% over five years.

Its highest close in our data was $120.9B in Feb 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$116.7B	$88.5B	$120.9B	+14%
2025	$102.2B	$73.3B	$108.8B	+40%
2024	$73.2B	$62.9B	$81.9B	+19%
2023	$61.6B	$46B	$62.4B	+16%
2022	$53.2B	$37.7B	$56.7B	+40%
2021	$38B	$27B	$38B	+36%
2020	$27.9B	$22.1B	$30.2B	+11%
2019	$25.1B	$21.5B	$28.2B	+17%
2018	$21.5B	$21.2B	$36.8B	−34%
2017	$32.5B	$28.3B	$35.3B	+2%
2016	$31.8B	$28.1B	$44.4B	−30%
2015	$45.4B	$41.1B	$55.7B	−7%
2014	$48.7B	$36.9B	$49.3B	+32%
2013	$37B	$23.6B	$38.1B	+63%
2012	$22.6B	$18.8B	$23.2B	+18%
2011	$19.1B	$17.3B	$21.4B	+7%
2010	$17.8B	$15.5B	$19B	+6%
2009	$16.7B	$13.6B	$17.2B	n/a

Companies in Healthcare nearest McKesson's size, closest first, today.

Company	Market cap
MCKMcKesson	$116.7B
SYKStryker	$117.8B
CVSCVS Health	$119.5B
MDTMedtronic	$122B
BMYBristol-Myers Squibb	$125.6B
VRTXVertex Pharmaceuticals	$132.8B
HCAHCA Healthcare	$101.5B
ELVElevance Health	$95.4B
ISRGIntuitive Surgical	$159.8B
DHRDanaher	$162B
REGNRegeneron Pharmaceuticals	$82.9B
Peer median	$120.8B